Cutia Therapeutics (2487.HK)
HKD 6.95
(0.14%)
HKD 6.95
(0.14%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -381.31 Million | -236.19 Million | -159.87 Million |
| Net Income | -1.96 Billion | -555.83 Million | -319.58 Million |
| Depreciation & Amortization | 42.48 Million | 18.92 Million | 9.79 Million |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 132.35 Million | 100.02 Million | 41.11 Million |
| Change in working capital | -5.42 Million | -29.1 Million | -34.04 Million |
| Other non-cash items | 1.43 Billion | 311.45 Million | 114.61 Million |
| Investing Cash Flow | -203.57 Million | 462.06 Million | -410.65 Million |
| Investments in PPE | -55.91 Million | -135.31 Million | -25.88 Million |
| Acquisitions | - | - | - |
| Investment purchases | -939.16 Million | -921.33 Million | -793.19 Million |
| Sales/Maturities of investments | 763.03 Million | 1.53 Billion | 418.14 Million |
| Other Investing Activities | -147.84 Million | 596.41 Million | -386.33 Million |
| Financing Cash Flow | 588.31 Million | -10.24 Million | 480.76 Million |
| Debt repayment | -189.2 Million | -6.88 Million | -3.08 Million |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 422.52 Million | - | - |
| Other Financing Activities | -1.13 Million | -985 Thousand | -148 Thousand |
| Accounts receivables | -62.85 Million | -98 Thousand | - |
| Accounts payables | - | - | - |
| Inventory | -25.31 Million | -18.19 Million | -1.8 Million |
| Other working capital | 17.94 Million | -32.37 Million | -32.65 Million |
| Cash at beginning of period | 465.86 Million | 203.13 Million | 300.17 Million |
| Cash at end of period | 473.12 Million | 465.86 Million | 203.13 Million |
| Capital Expenditure | -55.91 Million | -135.31 Million | -25.88 Million |
| Effect of forex changes on cash | 3.82 Million | 47.11 Million | -7.27 Million |
| Net cash flow / Change in cash | 7.25 Million | 262.73 Million | -97.04 Million |
| Free Cash Flow | -437.22 Million | -371.5 Million | -185.76 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -100.46 Million | -100.46 Million | -1.96 Billion | -161.7 Million | -161.7 Million | -820.16 Million |
| Depreciation & Amortization | 10.24 Million | 10.24 Million | 42.48 Million | 11.01 Million | 10.51 Million | 10.22 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 19.95 Million | 19.95 Million | 132.35 Million | 29.83 Million | 29.83 Million | 36.34 Million |
| Change in working capital | -19.19 Million | -19.19 Million | -5.42 Million | -21.02 Million | -21.02 Million | -14.08 Million |
| Other non-cash items | -33.63 Million | -33.63 Million | 1.43 Billion | 33.93 Million | 34.43 Million | 704.98 Million |
| Investing Cash Flow | 21.59 Million | 21.59 Million | -203.57 Million | -55.26 Million | -55.26 Million | -46.52 Million |
| Investments in PPE | -4.87 Million | -4.87 Million | -55.91 Million | -11.4 Million | -11.4 Million | -16.45 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -939.16 Million | - | - | - |
| Sales/Maturities of investments | - | - | 763.03 Million | - | - | - |
| Other Investing Activities | 26.47 Million | 26.47 Million | -147.84 Million | -43.85 Million | -43.85 Million | -30.07 Million |
| Financing Cash Flow | 2.67 Million | 2.67 Million | 588.31 Million | 54.52 Million | 54.52 Million | 239.63 Million |
| Debt repayment | - | - | -189.2 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 422.52 Million | - | - | - |
| Other Financing Activities | 2.67 Million | 2.67 Million | -1.13 Million | 54.52 Million | 54.52 Million | 239.63 Million |
| Accounts receivables | 4.44 Million | 4.44 Million | -62.85 Million | -29.45 Million | -29.45 Million | -1.97 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -10.57 Million | -10.57 Million | -25.31 Million | -12.18 Million | -12.18 Million | -474 Thousand |
| Other working capital | -13.05 Million | -13.05 Million | 17.94 Million | 20.6 Million | 20.6 Million | -11.63 Million |
| Cash at beginning of period | - | - | 465.86 Million | - | - | - |
| Cash at end of period | -98.53 Million | -98.53 Million | 473.12 Million | -110.21 Million | -110.21 Million | 113.84 Million |
| Capital Expenditure | -4.87 Million | -4.87 Million | -55.91 Million | -11.4 Million | -11.4 Million | -16.45 Million |
| Effect of forex changes on cash | 275.5 Thousand | 275.5 Thousand | 3.82 Million | -1.52 Million | -1.52 Million | 3.43 Million |
| Net cash flow / Change in cash | -98.53 Million | -98.53 Million | 7.25 Million | -110.21 Million | -110.21 Million | 113.84 Million |
| Free Cash Flow | -127.95 Million | -127.95 Million | -437.22 Million | -119.36 Million | -119.36 Million | -99.15 Million |
0543
ELO
DATS
SESG
TWR
NAH